8 European Projects Found
Searched on 125080 European Projects
FINISHED
Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection (FLUCOP)
Start date: Mar 1, 2015, End date: Feb 29, 2020,
...ew assays which might potentially used for future clinical trials for influenza seasonal vaccine evaluationFLUCOP Consortium and Project Impact: The FLUCOP consortium brings together 26 groups from 7 European countries, and includes contributors from the academic, governmental, non-for-profit and pharmaceutical sectors. As a whole, the consortium has a balanced array of expertise and each group ha ...
Read Project
26
Partners Participants
FINISHED
Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE)
Start date: Oct 1, 2013, End date: Sep 30, 2018,
...urces, and methods developed in other WPs via a series of public-private co-operative studies proof-of-concept studies. ADVANCE partners embrace the enormous potential to improve public health across European Member States by collaboratively utilizing the rich information generated in clinical routine care and captured in health care databases. While the ADVANCE Forum concept engages all stakehold ...
Read Project
30
Partners Participants
FINISHED
Recognising Adverse Drug Reactions (WEB-RADR)
Start date: Sep 1, 2014, End date: Aug 31, 2017,
WEB-RADR is a consortium of leading experts in pharmacovigilance from regulatory agencies, research, academia and patient support groups. Together with EFPIA partners our aims will be to set policy & guidance and deliver robust information technology tools to address the potential for the reporting of adverse drug reactions (ADRs) through mobile applications and the recognition of drug safety sign ...
Read Project
20
Partners Participants
FINISHED
Global Research in Paediatrics (GRiP)
Start date: Jan 1, 2011, End date: Jun 30, 2017,
Paediatric drugs (PD) lack appropriate testing. Most drugs have inadequate information about dosing regimen, dose adjustment and how to administer them. These are longstanding problems that unquestionably require concerted efforts at the international level. Both the US and the EU have introduced paediatric legislation that facilitates participation of children in research and pharmaceutical innov ...
Read Project
24
Partners Participants
FINISHED
Incorporating real-life clinical data into drug development (GETREAL)
Start date: Oct 1, 2013, End date: Dec 31, 2016,
When a new medicine reaches the market, it is accompanied by an extensive data package that provides information about the safety and efficacy of the medicine in a clinical trial setting. However, assessing the expected future value of the medicines when used in “real world” clinical practice requires additional information next to traditional (pre-authorisation) clinical trials. Regulatory, HTA ...
Read Project
32
Partners Participants
FINISHED
European programme in Pharmacovigilance and Pharmacoepidemiology (EU2P)
Start date: Sep 1, 2009, End date: Jun 30, 2016,
The Eu2P training network in Pharmacovigilance and Pharmacoepidemiology will meet the needs of industry,regulatory authorities and academia at the European level. It will give access to a harmonised training programme that gathers complementary specialized and eminent European partners. The Eu2P consortium consists of course providers with aproven record including the University of Bordeaux (Eu2P ...
Read Project
24
Partners Participants
FINISHED
Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT)
Start date: Sep 1, 2009, End date: Apr 30, 2015,
...eous reports and conflicting results from pharmacoepidemiology studies may lead to delay in, or inappropriate, regulatory decisions. The PROTECT consortium, consisting of 20 core partners lead by the European Medicines Agency (EMEA), willdevelop and test methods of proactive monitoring of drug safety and benefit risk (B/R) assessment utilising a large range of EU data sources and expertise. in par ...
Read Project
36
Partners Participants
FINISHED
Pharmaceutical Medicine Training Programme (PHARMATRAIN)
Start date: May 1, 2009, End date: Apr 30, 2014,
...d risk-awareness patient and population-based benefit as well as to make the process faster, more economical and more competitive with other parts of the world than hitherto. To address this, a pan-European comprehensive multi-modular training programme at the Master level – Master of Advanced Studies in Pharmaceutical Medicine/Drug Development Sciences (MDDS) – and other targeted programmes will ...
Read Project
